Altered exocrine function can drive adipose wasting in early pancreatic cancer-Reference-Cited by-同舟云学术

Altered exocrine function can drive adipose wasting in early pancreatic cancer

Published:2018-06 Issue:7711 Volume:558 Page:600-604
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Danai Laura V.,Babic Ana,Rosenthal Michael H.,Dennstedt Emily A.,Muir Alexander,Lien Evan C.,Mayers Jared R.,Tai Karen,Lau Allison N.,Jones-Sali Paul,Prado Carla M.,Petersen Gloria M.,Takahashi Naoki,Sugimoto Motokazu,Yeh Jen Jen,Lopez Nicole,Bardeesy Nabeel,Fernandez-del Castillo Carlos,Liss Andrew S.,Koong Albert C.,Bui Justin,Yuan Chen,Welch Marisa W.,Brais Lauren K.,Kulke Matthew H.,Dennis Courtney,Clish Clary B.,Wolpin Brian M.,Vander Heiden Matthew G.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-018-0235-7.pdf

Reference33 articles.

1. Koppenol, W. H., Bounds, P. L. & Dang, C. V. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325–337 (2011).

2. Petruzzelli, M. & Wagner, E. F. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 30, 489–501 (2016).

3. Dewys, W. D. et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med. 69, 491–497 (1980).

4. Mueller, T. C., Bachmann, J., Prokopchuk, O., Friess, H. & Martignoni, M. E. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia—can findings from animal models be translated to humans? BMC Cancer 16, 75 (2016).

5. Fearon, K., Arends, J. & Baracos, V. Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 10, 90–99 (2013).

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution;Cell Reports;2024-08

2. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma;Frontiers in Oncology;2024-07-23

3. Flubendazole presents anti-tumor effects by promoting cell cycle arrest and inhibiting the invadopodia in pancreatic cancer;2024-07-17

4. The ratio of skeletal muscle mass to body mass index combined with inflammatory immune markers to stratify survival of pancreatic cancer after pancreatoduodenectomy;European Journal of Surgical Oncology;2024-07

5. Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration;Cancers;2024-06-27